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Summary
Mitochondrial respiratory chain (MRC) complexes I, III and IV associate into a variety of 
supramolecular structures known as supercomplexes and respirasomes. While COX7A2L was 
originally described as a supercomplex-specific factor responsible for the dynamic association of 
complex IV into these structures to adapt MRC function to metabolic variations, this role has been 
disputed. Here we further examine the functional significance of COX7A2L in the structural 
organization of the mammalian respiratory chain. As in the mouse, human COX7A2L binds 
primarily to free mitochondrial complex III and to a minor extent to complex IV to specifically 
promote the stabilization of the III2+IV supercomplex without affecting respirasome formation. 
*Corresponding author: Dr. Cristina Ugalde, Instituto de Investigación, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 
28041 Madrid. Phone: +34 91 779 2784, FAX: +34 91 390 8544, cugalde@h12o.es.
8Co-first authors
Author Contributions: Conceptualization, Methodology and Investigation, R.P.P., T.L.J., D.M., A.M., A.B., A.G.B., E.F.V., I.G.C., 
and C.U.; Formal Analysis, A.D.; Writing, C.U.; Funding Acquisition, S.C., E.F.V., M.A.M., N.G.L., and C.U.; Resources, E.F.V., 
J.A., and N.G.L.; Supervision, S.C., N.G.L., and C.U.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Cell Rep. Author manuscript; available in PMC 2016 August 31.
Published in final edited form as:
Cell Rep. 2016 August 30; 16(9): 2387–2398. doi:10.1016/j.celrep.2016.07.081.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Furthermore, COX7A2L does not affect the biogenesis, stabilization and function of the individual 
OXPHOS complexes. These data show that independent regulatory mechanisms for the biogenesis 
and turnover of different MRC supercomplex structures co-exist.
Graphical abstract
Introduction
The oxidative phosphorylation (OXPHOS) system is embedded in the lipid bilayer of the 
inner mitochondrial membrane and is composed of five multiprotein enzyme complexes as 
well as the two mobile electron carriers coenzyme Q (or Q) and cytochrome c (cyt c). The 
first four enzyme complexes (CI-CIV) comprise the mitochondrial respiratory chain (MRC), 
which facilitates electron transfer from reducing equivalents to molecular oxygen. The 
electron translocation through the MRC is coupled to the creation of a proton gradient across 
the inner mitochondrial membrane that will be used by the ATP synthase (complex V) to 
drive ATP synthesis. In recent years, it has been widely demonstrated that MRC complexes 
I, III and IV (CI, CIII, CIV) may associate to form a diversity of supramolecular assemblies 
known as supercomplexes (SCs) or respirasomes (Cruciat et al., 2000; Schagger and Pfeiffer, 
2000). However, the functional relevance of mitochondrial SCs is a matter of intense debate 
though they are conserved across species. In mammals, the respirasome is often referred to 
as SC I+III2+IV1-4. Biochemical analyses support the idea that the respirasome contains the 
MRC and the electron carriers and thus is a structural entity that can carry out respiration on 
its own (Acin-Perez et al., 2008). Some authors have proposed that SCs function to confer 
stability to CI (Moreno-Lastres et al., 2012; Schagger et al., 2004), to reduce reactive 
oxygen species (ROS) production (Maranzana et al., 2013), to facilitate electron channeling 
(Bianchi et al., 2004) and to mediate metabolic adaptation through the partition of Q into 
two different pools (Lapuente-Brun et al., 2013). However, the view that SC assemblies 
provide distinct electron translocation pathways is currently disputed. Kinetic and 
spectroscopic studies have challenged the substrate channeling model by concluding that (i) 
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cyt c is not trapped within the SCs and therefore it does not encounter any restriction of its 
diffusion (Trouillard et al., 2011), and (ii) the metabolic pathways for NADH and succinate 
oxidation impose different coenzyme Q redox steady state but communicate and converge 
on a single non-partitioned coenzyme Q pool (Blaza et al., 2014; Rigoulet et al., 2010). 
Moreover, cryo-electron microscopy analyses of the mammalian SC I+III2+IV1 does not 
support the substrate channeling model because the distance between the binding sites for 
coenzyme Q on CI and CIII, as well as the distance between the binding sites for cyt c on 
CIII and CIV, are sufficiently far away to allow free exchange (Althoff et al., 2011; Dudkina 
et al., 2011). Instead, it has been suggested that the relatively weak interactions between the 
MRC complexes that lead to SCs formation, could prevent deleterious protein aggregation in 
the densely packed inner mitochondrial membrane (Blaza et al., 2014). According to this 
latter idea, SCs formation would have no direct bioenergetic role but rather be a protective 
mechanism that prevents tight interactions between the individual OXPHOS complexes.
In budding yeast lacking CI, the formation and stabilization of the mitochondrial SC 
III2+IV1-2 is controlled by specific regulatory proteins called the respiratory supercomplex 
factors 1 and 2 (Rcf1 and Rcf2) (Chen et al., 2012; Strogolova et al., 2012; Vukotic et al., 
2012). While both proteins are preferentially associated with CIV, only Rcf1 seems to play a 
crucial role in SC stability, as it does its human ortholog HIG2A (Chen et al., 2012). A 
highly controversial issue involves the potential regulatory role of the protein COX7A2L/
COX7RP in the formation and stabilization of mitochondrial SCs. Mouse COX7A2L was 
reported to be present in SC III2+IV and the respirasomes, but not in free complex III or IV 
(Lapuente-Brun et al., 2013; Müller et al., 2015), and was therefore renamed the SC-specific 
assembly factor I (SCAFI). Certain wild-type mouse strains, e.g. C57BL/6J and BALB/c, 
are homozygous for a 6 bp deletion in the Cox7a2l gene and therefore express a short, 
unstable COX7A2L variant that was reported to lead to a failure to form SC III2+IV and 
respirasomes (Lapuente-Brun et al., 2013). Remarkably, the respiration rates and ATP 
production from CI and CII-linked substrates were reported to be higher in tissues from 
mice bearing the short COX7A2L isoform. The authors suggested that COX7A2L could 
mediate binding of CIV to SCs to physiologically regulate energy metabolism by providing 
alternate paths for electrons from different metabolic sources (NADH, FAD, or both), thus 
allowing optimization of respiration to substrate availability (for discussion, see (Barrientos 
and Ugalde, 2013)). Another study used Cox7a2l knockout mice (Ikeda et al., 2013) and 
reported that COX7A2L is a SC-specific factor that, in contrast to the previous model 
(Lapuente-Brun et al., 2013), would promote respirasome stability to gain full activity of the 
MRC. The knockout study showed that respirasomes were present in mitochondria from 
skeletal muscle of C57BL/6J mice (Ikeda et al., 2013), despite previous claims that this 
mouse strain lacks respirasomes (Lapuente-Brun et al., 2013). In agreement, an in depth 
characterization of isolated heart and liver mitochondria from control mouse strains that 
either contained the full-length Cox7a2l gene (i.e., CD1 mice) or the variant with the 6 bp 
deletion (i.e., C57BL/6J, C57BL/6N and BALB/c mice), demonstrated that all mice had 
normal formation of respirasomes and normal respiratory chain function, thus showing that 
the truncated version of the Cox7a2l gene does not impact the bioenergetic capacity in vivo 
(Mourier et al., 2014a).
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The aim of the present work was to elucidate the functional importance of COX7A2L in the 
structural organization of the mammalian OXPHOS system. Our study demonstrates that 
COX7A2L preferentially interacts with mitochondrial CIII and to a minor extent with CIV 
to promote stabilization of the SC III2+IV in both mice and humans. However, COX7A2L 
has no role in the biogenesis, stabilization and function of the free OXPHOS complexes and 
it has no role in the formation of the respirasomes. These data show the co-existence of 
alternative regulatory mechanisms for the biogenesis and turnover of different respiratory 
chain SC structures.
Results
Mouse COX7A2L is essential for SC III2+IV formation in a respirasome-independent 
manner
In order to shed light on these contradictory conclusions regarding COX7A2L function in 
murine models (Ikeda et al., 2013; Lapuente-Brun et al., 2013; Mourier et al., 2014a), we 
first analyzed the COX7A2L levels relative to OXPHOS subunits by western blots in 
isolated heart mitochondria from CD1 versus C57BL/6 mice (Figure S1A). The allelic 
variation of the Cox7a2l gene in nuclear DNA is previously described (Mourier et al., 
2014a). The CD1 mice express high levels of a 113 amino acid COX7A2L protein isoform, 
whereas C57BL/6 mice express low levels of a slightly shorter and unstable COX7A2L 
protein isoform of 111 amino acids. CI and CIV subunits were present at similar levels in the 
wild-type CD1, C57BL/6J and C57BL/6N mice strains. However, the levels of COX7A2L 
and CIII subunits were slightly increased in the CIV-deficient conditional Lrpprc knockout 
mice compared with their wild-type littermates that all were maintained on the C57BL/6N 
background (Mourier et al., 2014b). These data suggest that COX7A2L as well as CIII are 
stabilized in the Lrpprc knockout mice as a response to the severe CIV deficiency.
In agreement with a previous report (Mourier et al., 2014a), BN-PAGE analysis of digitonin-
solubilized heart mitochondria from CD1 and C57BL/6 mice confirmed similar levels and 
activities of the respirasomes in all wild-type strains (Figures 1A-B). Analysis of COX7A2L 
distribution in CD1 mice (Figure 1C) showed its preferential co-segregation with free CIV, 
SC III2+IV and respirasomes, and to a minor extent with the CIII dimer. In the C57BL/6 
mice, however, COX7A2L was mostly found in CIII-containing structures (Figure 1C). 
These data suggest that the two-amino acid deletion and consequent reduction in COX7A2L 
levels mostly hampers the binding of COX7A2L to CIV, which nevertheless only provoked 
the disappearance of SC III2+IV (Figures 1B-C), without affecting free CIV or respirasome 
levels and activities (Figures 1A-C). Thus, the severely reduced COX7A2L levels in 
C57BL/6 mice do not hamper the association of CIV with the respirasomes, as previously 
proposed (Lapuente-Brun et al., 2013). To test whether the respirasome stability depends on 
COX7A2L levels, we exposed heart mitochondria from CD1 and C57BL/6J mice to 
increasing amounts of the detergent digitonin followed by BN-PAGE analysis (Figure S1B). 
Respirasome levels and organization were comparable between both mouse strains at the 
low digitonin-to-protein ratios. Also under the most stringent detergent conditions, 
respirasomes were still clearly detectable in the C57BL/6J mice albeit at slightly lower 
levels than in the CD1 mice. Noteworthy, SCs from both mouse strains reorganized in 
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different ways upon increasing digitonin treatment and some respirasome bands appeared to 
be more stable in C57BL/6J than in CD1 mice, and vice versa. We next analyzed DDM-
solubilized mouse heart mitochondria, condition in which respirasomes are disrupted (Figure 
S1C), and found that the co-segregation between COX7A2L and free CIV was totally lost, 
suggesting that their interaction is indeed labile. In CD1 mice, both COX7A2L and the CIII 
subunit CORE2 co-localized with the CIII dimer and SC III2+IV, whereas in C57BL/6 mice 
both proteins only were present in the CIII dimer. These data show that COX7A2L is 
essential for SC III2+IV stability, whereas it is dispensable for the respirasome formation.
Next we assessed import and assembly of the radiolabeled 113 amino acid COX7A2L 
isoform into isolated heart mitochondria from CD1, C57BL/6J and C57BL/6N mice by BN-
PAGE analyses (Figures 1D and S1D-E). We used mitochondria with dissipated membrane 
potential as controls to ensure that the protein import and assembly depends on the 
membrane potential across the inner mitochondrial membrane (Figure S1D). The 
comparison of migration patterns and the kinetics of formed assembly intermediates after 
import of COX7A2L or the CIII subunit RISP showed that the long COX7A2L isoform was 
incorporated into CIII-containing structures in all mice strains. We observed a preferential 
co-segregation of the newly imported COX7A2L with the CIII dimer at early time points 
after import (Figure 1D), whereas COX7A2L was present in higher molecular weight 
structures, such as SC III2+V and respirasomes, at later time points. These data demonstrate 
that COX7A2L preferentially interacts with CIII prior to SC formation. Additional import 
analyses of COX7A2L into isolated mitochondria from Lrpprc wild-type and knockout 
hearts (Figure S1E) revealed that COX7A2L associates with CIII independently of the 
presence of CIV.
Human COX7A2L co-localizes with respiratory chain complexes III and IV, and complex III-
containing supercomplexes
In humans, only one COX7A2L protein of 114 amino acids has been reported in the NCBI 
database (http://www.ncbi.nlm.nih.gov/gene/9167). To clarify the functional role of the 
human COX7A2L protein, we first analyzed its distribution pattern in relation to free MRC 
complexes and SCs by performing BN-PAGE followed by western blot analyses. We 
analyzed digitonin-solubilized mitochondria from control 143B cells and cybrids with a 
severe CI assembly defect (CI-KD), total lack of CIII (CIII-KO) or total lack of CIV (CIV-
KO) (Figures 2A and S2A). In controls, COX7A2L co-localized not only with SC III2+IV 
and the respirasomes (SC I+III2+IVn), as previously described in murine models (Lapuente-
Brun et al., 2013; Müller et al., 2015), but also with SC I+III2, the CIII dimer (CIII2) and 
free CIV. The CI-KD cybrids, which harbored a >90% heteroplasmic mutation in the MT-
ND2 subunit gene of mtDNA (Ugalde et al., 2007), showed a strong reduction in the levels 
of SC I+III2+IVn, SC III2+IV and free CIV. Consistently, the amounts of COX7A2L within 
those structures were also reduced in the CI-defective cells compared with the controls. The 
CIII-KO cybrids lacked CIII due to a homoplasmic 4–base pair deletion in the MT-CYB 
gene that encodes cytochrome b (Rana et al., 2000). Lack of CIII caused the complete 
disruption of SC I+III2+IVn and SC III2+IV accompanied by increased levels of free CIV 
and CIV oligomers. In addition, a dramatic reduction in COX7A2L levels, comparable to 
that of the CIII structural subunits, was observed (Figure 2B). Only a minor residual 
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COX7A2L signal co-migrating with free CIV was seen at the longest exposures (Figure 
S2B), indicating that the lack of CIII profoundly affects the stability of COX7A2L and its 
binding to CIV. The CIV-KO cybrids harbor a homoplasmic nonsense mutation in MT-CO1 
(Bruno et al., 1999), leading to the disappearance of free CIV, SC III2+IV and SC I
+III2+IVn, accompanied by an accumulation of SC I+III2 and CIII2. Interestingly, 
COX7A2L could bind SC I+III2 and CIII2 in the absence of CIV, whereas very small 
amounts were bound to CIV in the absence of CIII. Thus, in human cells COX7A2L 
preferentially associates with CIII2 and CIII-containing structures and only to a minor extent 
with free CIV, showing that COX7A2L principally behaves as a CIII interactor rather than 
an assembly factor exclusive to CIV-containing SCs (Lapuente-Brun et al., 2013). The 
presence of COX7A2L in CIII2, SC I+III2 and I+III2+IVn was further confirmed by high-
resolution nano-LC/ESI-MS proteomic analysis of the blue native gel bands corresponding 
to SC I+III2+IVn in 143B cells, and to SC I+III2 and CIII2 in the CIV-KO mutant cybrids 
(Figures 2C-D and Table S1).
Overexpressed COX7A2L is imported into mitochondria and binds complexes III and IV 
without significantly enhancing supercomplex formation
We next investigated the cellular localization of human COX7A2L by transfecting control 
143B cells with a construct expressing COX7A2L with a C-terminal GFP-tag, of∼ 39.3 kDa 
(Figure S3A). Confocal microscopy showed co-localization of COX7A2L-GFP with the 
ATP synthase (complex V), thus confirming mitochondrial localization of the fusion protein 
(Figure 3A). Next, we analyzed by BN-PAGE the mitochondrial distribution of exogenous 
COX7A2L and the effect of COX7A2L overexpression on the assembly of the OXPHOS 
system. To this end, we initially used 143B cells transfected either with the GFP-tagged 
COX7A2L construct or with a vector that expressed COX7A2L with a C-terminal MYC-
DDK-tag, of∼ 16.2 kDa (Figures 3B and S3B). In 143B cells, COX7A2L-GFP was 
effectively overexpressed by∼ 15-fold relative to the endogenous COX7A2L (Figure S3A), 
while COX7A2L-MYC-DDK was overexpressed by∼ 2-fold (Figure S3B). BN-PAGE 
analyses confirmed the co-migration of exogenous COX7A2L with the CIII dimer, free CIV, 
SC III2+IV and with the respirasomes in digitonin-solubilized mitochondria (Figures 3B and 
S3C), thus showing that COX7A2L with both tags are efficiently incorporated into MRC 
complexes and SCs. Densitometric analyses of OXPHOS subunit distribution showed that 
the overexpression of tagged-COX7A2L induced no significant increase in the amounts of 
CIII- and CIV-containing structures (Figure 3C). We extended this analysis to HEK293 cells 
transfected with either the MYC-DDK-tagged COX7A2L construct or the MYC-DDK tag 
alone. In HEK293 cells, COX7A2L-MYC-DDK was effectively overexpressed by∼ 10-fold 
relative to endogenous COX7A2L (Figure S3B), and co-migrated with the CIII dimer, free 
CIV, SC III2+IV and the respirasomes (Figure S3D). Tagged-COX7A2L overexpression in 
HEK293 cells neither altered the levels of MRC complexes or SCs.
Next, we tested whether the COX7A2L co-localization with MRC complexes III and IV was 
due to a direct physical interaction. We performed co-immunoprecipitation assays of 
digitonin-solubilized mitochondrial lysates from HEK293 cells transfected with either the 
COX7A2L-MYC-DDK construct or the empty vector (Figure 4A). Immunoprecipitation 
with an anti-DDK antibody specifically pulled down the tagged-COX7A2L protein in cells 
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overexpressing COX7A2L-MYC-DDK. In addition, the CIII subunits CORE1, CORE2, 
CYC1, RISP and UQCRQ, and the CIV subunits COX1, COX4, COX5B and COX6C were 
detected in the co-immunoprecipitate (co-IP). The CI subunits NDUFA9 and NDUFS1 were 
barely detectable and CII was not detected in the co-IP samples. When reverse 
immunoprecipitation assays were performed using antibodies against CORE2 or COX1 
proteins, both the tagged and the endogenous COX7A2L proteins were successfully pulled 
down (Figures 4B-C). Importantly, immunoprecipitation with CORE2 (but not with COX1) 
pulled down the endogenous COX7A2L protein in cells transfected with the empty vector. 
These data show that COX7A2L physically interacts with complexes III and IV, but presents 
a higher affinity for CIII. According to the TOPCONS prediction software (http://
topcons.cbr.su.se/), human COX7A2L contains one transmembrane domain that spans 
amino acids 86 to 107, leaving most of the N-terminal part of the protein exposed to the 
mitochondrial matrix, and a short C-terminal stretch of 7 amino acids facing the inter 
membrane space. The direct association of COX7A2L with mitochondrial complexes III and 
IV is therefore compatible with its predicted topology.
Endogenous COX7A2L associates with respiratory chain complexes III and IV and with 
supercomplexes during their assembly process
We next analyzed the assembly kinetics of COX7A2L into MRC complexes and SCs by 
doxycycline-induced reversible inhibition of mitochondrial translation in control 143B cells 
(Moreno-Lastres et al., 2012). Doxycycline was removed from cell culture media after 6 
days of treatment, and samples were collected at different time points (0, 6, 15, 24, 48, 72 
and 96 hours). To follow the integration of endogenous COX7A2L into newly-assembled 
CIII, CIV and SCs, digitonin-solubilized mitochondria were separated by 2D-BN/SDS-
PAGE and subsequently analyzed by western blot using antibodies that recognize 
COX7A2L, CORE2 (CIII), RISP (CIII) and COX5A (CIV) (Figure 5A). Signals from at 
least three independent experiments were quantified by densitometry, normalized to CII 
levels and values were expressed relative to levels in untreated cells (SS, Figures 5B-C and 
S4A-D). After 6 days of doxycycline treatment (time 0h), there was a drastic decrease 
(80-95%) in the levels of the CIII dimer (CIII2), CIV, SC III2+IV and SC I+III2+IVn, as well 
as in the levels of COX7A2L that co-localizes with these structures. The CII levels remained 
normal after doxycycline treatment (not shown) as expected because this complex lacks 
mtDNA-encoded subunits. Once mitochondrial translation resumed (times 6-96 h, Figures 
5B-C), we observed a gradual increase of the levels of COX7A2L protein that co-localized 
with CIII2, in agreement with our previous results showing co-localization of newly-
imported COX7A2L and the CIII dimer in mouse heart mitochondria (Figure 1D). The 
incorporation of COX7A2L into CIII occurred in parallel to the insertion of the CORE2 
subunit, which gets assembled into CIII prior to the incorporation of RISP (Figure S4A). In 
contrast, the CIV levels increased prior to the binding of COX7A2L (Figure S4B), 
suggesting that COX7A2L only binds fully-assembled CIV. Once COX7A2L had bound to 
CIV, there was a simultaneous increase of the levels of COX7A2L in CIV and SC III2+IV 
(Figures 5B-C). Moreover, COX7A2L was incorporated into SC III2+IV in parallel with the 
CORE2 and COX5A subunits, but prior to the integration of RISP in this structure (Figure 
S4C). The incorporation of COX7A2L into respirasomes occurred concomitantly with the 
integration of CORE2 and COX5A, and earlier than the integration of RISP (Figure S4D), 
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which indicates that COX7A2L is incorporated before the respirasome formation is 
completed.
COX7A2L associates with complex III and supercomplex III2+IV prior to the insertion of the 
RISP catalytic subunit
In the reported CIII assembly models, incorporation of CORE2 allows the formation of a 
non-functional intermediate called pre-CIII, which contains CORE2 and the rest of CIII 
subunits except RISP and the smallest subunit (Qcr10 in yeast, UQCR11 in mammals), 
which are incorporated at a later assembly stage (Fernandez-Vizarra and Zeviani, 2015; 
Smith et al., 2012). This late assembly step is promoted by LYRM7/MZM1L, an assembly 
factor that binds RISP to stabilize it prior to its incorporation into CIII. HeLa cells that 
stably overexpress HA-tagged MZM1L show sequestering of RISP in a small subcomplex, 
thereby preventing CIII maturation (Sánchez et al., 2013). Doxycycline experiments 
suggested that human COX7A2L could be a component of pre-CIII, as this protein gets 
incorporated into CIII in parallel with the CORE2 subunit but before the incorporation of 
RISP (Figure S4A). To confirm this hypothesis, we analyzed COX7A2L distribution by BN-
PAGE of digitonin-solubilized mitochondria isolated from HeLa cells overexpressing 
MZM1L-HA (Figure 6). As observed by CI in gel activity (IGA), MZM1L over expression 
induced a decrease in the levels and activity of the respirasomes (SC I+III2+IV), as well as 
an accumulation of CI-containing structures (Figure 6A). As expected, the levels of the RISP 
subunit were strongly decreased in the respirasomes, SC III2+IV and in the CIII dimer, and 
there was a parallel accumulation of RISP in a small subcomplex that also contains 
MZM1L-HA (Sánchez et al., 2013) (Figure 6B). The amount of RISP remained relatively 
high in SC I+III2+IV compared with other structures, suggesting that this subunit is stably 
bound to the respirasomes. Upon MZM1L/LYRM7 overexpression, CORE2 and COX7A2L 
co-segregated with pre-SC III2+IV and pre-CIII (Figure 6B), further supporting that 
COX7A2L associates with pre-CIII before the incorporation of RISP takes place (Figure 
S4E). All in all, our data demonstrate that in human cells, the interaction of COX7A2L with 
CIV depends on the presence of pre-CIII, which formation is not affected by the lack of 
RISP (Figure 6) but is dependent on cytochrome b (Figure 2B).
COX7A2L downregulation causes supercomplex III2+IV disassembly without altering 
respirasome stability or respiratory chain function
We further investigated the effect of COX7A2L knockdown on mitochondrial function by 
using a mix of two small interfering RNAs (siRNAs) targeting exons 2 and 3 of COX7A2L 
mRNA. The COX7A2L knockdown efficiency was analyzed by SDS-PAGE of whole cell 
protein extracts from control 143B cells and CIV-KO mutant cybrids (Figures S5A-B). 
COX7A2L RNAi effectively knocked down the COX7A2L protein by 80% in the 143B cells 
and by 74% in the CIV-KO mutants, compared with cells transfected with unspecific 
scrambled siRNAs (C-). Next we analyzed the effects of COX7A2L silencing on OXPHOS 
system assembly by BN-PAGE in combination with CI in-gel activity and Western-blot 
analyses of mitochondrial-enriched fractions from 143B and CIV-KO cells (Figure 7A). 
Upon COX7A2L knockdown, there was a significant decrease in the signals of COX7A2L 
that co-localized with the CIII dimer, free CIV, and SCs III2+IV, I+III2 and I+III2+IVn. 
Despite the severe drop in COX7A2L levels we only observed a specific reduction in the 
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levels of SC III2+IV in the 143B cells, whereas the CI activity as well as levels of free 
OXPHOS complexes, other SCs and respirasomes were normal.
To gain deeper insight into the nature of SC III2+IV disruption in 143B cells, we performed 
2D-BN/SDS-PAGE and western blot analyses with antibodies against CORE2 (CIII), RISP 
(CIII), COX1 (CIV) and COX5B (CIV) (Figure 7B). Quantification of results from five 
independent experiments (Figures 7C and S5C-D) showed that COX7A2L knockdown 
specifically led to a significant decrease in the levels of the four analyzed subunits within SC 
III2+IV, but not in the other CIII- and CIV- containing structures. These data indicate that 
COX7A2L has a specific role in the stabilization of SC III2+IV, but not in the respirasome 
maintenance. Moreover, COX7A2L silencing did not result in a clear accumulation of 
intermediates smaller than complexes III and IV, indicating that their assembly and/or 
stability are not disturbed. In agreement with these results, COX7A2L knockdown in the 
CIV-KO mutant cybrids produced no significant alterations in the levels of the CIII dimer or 
SC I+III2 (Figures S6A-B). Altogether, our results show that the stabilization of SC III2+IV 
relies on the association of COX7A2L with MRC complexes III and IV.
Finally, we measured oxygen consumption rates (OCR) in 143B cells and found no 
significant differences between COX7A2L-silenced cells and cells transfected with 
scrambled siRNA (Figure S6C). In contrast, mitochondrial respiration was drastically 
reduced in the CI-KD cybrids that retained SC III2+IV but showed minimal levels of CI and 
respirasomes (Figure S6D). Respiratory chain activities measured in COX7A2L-silenced 
143B cells were also comparable to the activities in control cells (Figure S6E). These results 
show that a substantial loss of COX7A2L and SC III2+IV has no significant impact on MRC 
function in human cell lines.
Discussion
We have investigated the role of COX7A2L/COX7RP in the structural organization of the 
mammalian OXPHOS system, and clarified the apparent contradictions about the role of this 
protein in the literature (Ikeda et al., 2013; Lapuente-Brun et al., 2013; Mourier et al., 
2014a). Our data demonstrate that COX7A2L acts as a CIII-binding protein in mitochondria 
from mouse heart and human cell lines. Furthermore, COX7A2L is specifically required for 
SC III2+IV maintenance and this finding strongly argue against its previously proposed 
function as a SC-specific assembly factor that mediates respirasome formation.
We used a combination of COX7A2L immunodetection, high-throughput proteomics and 
mitochondrial in vitro import assays to demonstrate that COX7A2L co-migrates with the 
CIII dimer, free CIV, SC I+III2+IVn, SC I+III2 and SC III2+IV in both mice and humans. 
Thus, the COX7A2L protein is not exclusively present in SCs, as previously reported 
(Lapuente-Brun et al., 2013; Müller et al., 2015), but instead it predominantly associates 
with different CIII-containing structures. In mice, the long COX7A2L isoform preferentially 
interacts with CIII prior to SC formation. The small amount of COX7A2L that co-segregates 
with free CIV in the CD1 strain could reflect continuous turnover and exchange cycles 
between the SC-bound and free CIV states, or alternatively, a fraction of the COX7A2L-
bound CIV could be dissociated from SCs upon detergent extraction. Such dissociation 
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cannot be observed in the C57BL/6 mice because they have already lost the association 
between COX7A2L and CIV. Our data in human control and mutant cybrids lacking one 
MRC complex suggest that COX7A2L behaves as a structural component of CIII because 
COX7A2L preferentially binds this complex and the stability of COX7A2L depends on the 
presence of CIII. Accordingly, COX7A2L remains associated with the CIII dimer and CIII-
containing SCs in the absence of complexes I and IV. Furthermore, COX7A2L binds to a 
reported CIII assembly intermediate that lacks the RISP subunit (pre-CIII) before it interacts 
with free CIV, SC III2+IV or the respirasomes. In agreement with this observation, 
COX7A2L remained associated with pre-CIII in HeLa cells with an impaired incorporation 
of RISP. In contrast, lack of cytochrome b precludes the formation of pre-CIII and led to the 
disappearance of CIV-associated COX7A2L.
At variance with previous studies in fibroblasts from COX7A2L deprived mice (Lapuente-
Brun et al., 2013), COX7A2L overexpression in human cell lines did not cause a significant 
increase in the levels of MRC complexes III, IV or SCs. However, reduced COX7A2L levels 
led to a specific loss of SC III2+IV, but did not affect the amounts of free complexes III and 
IV, respirasomes or mitochondrial function. Similar to the situation in cultured human cells, 
the mouse COX7A2L variant of 113 amino acids is imported into mitochondria, where it 
preferentially associates with CIII-containing structures and plays an essential role in SC 
III2+IV stabilization. These results show that mammalian COX7A2L is essential to maintain 
SC III2+IV stability, but it plays no critical role in the assembly or stabilization of SC I
+III2+IVn. These findings strongly suggest that there are independent regulatory 
mechanisms for the biogenesis and turnover of SC III2+IV and the respirasomes. This is in 
accordance with previous observations suggesting that SC III2+IV gets fully-assembled after 
the completion of respirasome formation (Moreno-Lastres et al., 2012). Our current results 
also confirm that the levels of respirasomes and MRC activities in mitochondria from mouse 
hearts are not dependent on the allelic variations of Cox7a2l (Mourier et al., 2014a), and 
contradict the hypothesis that COX7A2L is an assembly factor that regulates respirasome 
formation to modulate respiration. The fact that respirasomes (but not SC III2+IV) are 
present in C57BL/6J mitochondria solubilized with a variety of detergent concentrations 
provides additional support for a role for COX7A2L to stabilize SC III2+IV. These data are 
in agreement with previous reports that show the presence of respirasomes in different 
tissues, including heart, liver and skeletal muscle, of C57BL/6 mice (Hatle et al., 2013; 
Ikeda et al., 2013; Jha et al., 2016; Milenkovic et al., 2013). In this regard, the previously 
reported absence of respirasomes in mouse strains with the truncated Cox7a2l allele 
(Lapuente-Brun et al., 2013) could have resulted from differences in the methodologies or 
reagents used for membrane solubilization. Indeed, we observed some variations in the 
intensity of SC isoforms between C57BL/6J and CD1 mice at high detergent concentrations; 
however the pattern was not constant, as specific SCs were stabilized in C57BL/6J mice but 
not in CD1 mice and vice versa. Based on our data we cannot exclude the possibility that the 
mechanisms of SC assembly are regulated in a tissue-dependent manner as recently 
proposed (Jha et al., 2016). However, it is important to acknowledge that the observed 
changes may not necessarily be a consequence of genetic COX7A2L variation, but could 
well be explained by other types of genetic differences among mouse strains.
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Our results argue that COX7A2L is permanently associated with CIII and that it exists in 
association/dissociation equilibrium with CIV, which can define the fate of CIV depending 
on whether COX7A2L is bound or not. This could provide a mechanism whereby 
COX7A2L-bound CIV is guided to the proximity of CIII to form and stabilize SC III2+IVn. 
The functional role of COX7A2L may resemble that described for HIG2A, the human 
ortholog of the yeast Rcf1 SC factor. In yeast, Rcf1 and Rcf2 preferentially associate with 
CIV to mediate SC III2+IV1-2 stability (Chen et al., 2012; Strogolova et al., 2012; Vukotic et 
al., 2012). Whereas Rcf2 is yeast-specific, several human homologs of Rcf1 have been 
reported, whereof HIG2A is involved in the stabilization of a proportion of CIV-containing 
SCs (Chen et al., 2012). C11ORF83 or UQCC3A, a cardiolipin-binding protein involved in 
early stages of human CIII assembly, has also been reported to act as a SC III2+IV 
stabilizing factor (Desmurs et al., 2015). The similarities in modes of action between these 
proteins and COX7A2L make it conceivable that they could act in conjunction having a 
respiratory chain “stabilizing” or “gluing” function, although further studies are required to 
demonstrate such functional interactions.
Interestingly, the COX7A2L-mediated absence of SC III2+IVn does not affect respirasome 
formation or maintenance. In addition, the fact that the formation and stabilization of a less 
abundant structure such as SC III2+IVn is regulated by specific proteins in a respirasome-
independent manner supports the existence of alternative assembly pathways for SC 
III2+IVn and the respirasomes. It may also be indicative of a specific, yet not well 
understood, physiological importance of SC III2+IVn. Results from others have suggested 
that SC III2+IVn could provide a MRC structure to receive electrons from CII (Lapuente-
Brun et al., 2013). However, given current evidence that puts in doubt the catalytic roles for 
mitochondrial SCs (Blaza et al., 2014; Trouillard et al., 2011), alternative non-catalytic 
functions should also be considered. These would include the regulation of MRC complexes 
distribution in specific cardiolipin microdomains within the densely protein-packed 
mitochondrial inner membrane, or a role in storage or preservation of excess MRC 
components to avoid futile continuous cycles of turnover and de novo synthesis. The 
experimental evidence of independent regulatory mechanisms and proteins for the 
biogenesis of intermediate SCs and the respirasomes opens new doors for exciting future 
investigations of the role for these supramolecular structures in the regulation of cellular 
energy supply.
Experimental Procedures
Cell Cultures
The CI-deficient cell line (CI-KD) harbors a homoplasmic m.4681T>C mutation in the MT-
ND2 subunit gene that leads to a severe CI assembly defect due to a p.L71P substitution 
(Ugalde et al., 2007). The CIII mutant (CIII-KO) cell line contains a homoplasmic 4–base 
pair deletion in the MT-CYB gene affecting the de novo synthesis of cytochrome b (Rana et 
al., 2000). The CIV mutant cell line (CIV-KO) lacks holo-COX due to the homoplasmic m.
6930G>A transition in the MT-COI gene, which creates a stop codon that results in a 
predicted loss of the last 170 amino acids of the COX1 polypeptide (Bruno et al., 1999). 
HeLa cells, either transduced with the empty pWPXLd-ires-PuroR vector or overexpressing 
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LYRM7-001-HA (MZM1L-HA), were generated as previously described (Sanchez et al., 
2013).
Cells were cultured in high-glucose Dulbecco's modified Eagle's medium (DMEM, Life 
Technologies) supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine, 1 mM 
sodium pyruvate, and antibiotics. To block mitochondrial translation, 15 μg/ml doxycycline 
was added for six days to the culture medium. Cells were grown in exponential conditions 
and harvested at the indicated time points.
In vitro Import
Radiolabeled COX7A2L, COX6A and RISP proteins were obtained by coupled transcription 
and translation in the presence of 35S-methionine (PerkinElmer) using TNT SP6 Quick 
Coupled System (Promega). Import experiments were performed on freshly isolated 
mitochondria from heart tissue as described before (Mourier et al., 2014a).
Immunoprecipitation
One milligram of mitochondrial protein from HEK293 transduced cells was solubilized in 
600 μl of 4 g /g digitonin-to-protein buffer as for BNE analyses. After centrifugation for 30 
min at 13,000 rpm at 4 °C, 50 μg of the supernatant was separated as the input fraction. The 
remainder supernatant was co-immunoprecipitated in resin spin columns (Pierce Co-IP Kit, 
Thermo Scientific) in which 15 μg of antibodies against DDK-tag (Oncogene), CORE2 or 
COX1 had been previously immobilized. The mixture was gently incubated overnight at 4°C 
in a rotating shaker and centrifuged at 1000 g for 1 min to separate the flow-through 
fraction. The column was washed three times with Lysis Buffer containing 1% NP-40 and 
proteins were eluted. The immunoprecipitate was divided into three aliquots, treated with 5× 
Loading Sample Buffer and heated at 95 °C for 5 minutes prior to loading.
Blue Native Electrophoresis and In-Gel Activity Assays
Mitochondrial pellets and blue native analyses were performed as described before (Moreno-
Lastres et al., 2012; Mourier et al., 2014a). Native PAGE™ Novex® 3-12% Bis-Tris Protein 
Gels (Life Technologies) or self-made 4-10% polyacrylamide gradient gels were loaded with 
60-80 μg of mitochondrial protein. After electrophoresis, proteins were transferred to 
nitrocellulose or PVDF membranes at 40 V overnight and probed with specific antibodies.
Antibodies
Western blot was performed using primary antibodies raised against COX7A2L 
(ProteinTech), Myc (Origene), turbo-GFP (Origene), HA (Roche), β-actin (Sigma), and 
against the following human OXPHOS subunits: NDUFS1 (GeneTex); NDUFA9, NDUFB8, 
CORE2, RISP, CYC1, UQCRB, UQCRQ, COX1, COX4, COX5A, COX6C, SDHA, SDHB 
(Mitosciences); and COX5B (Santa Cruz). Peroxidase-conjugated anti-mouse and anti-rabbit 
IgGs were used as secondary antibodies (Molecular Probes). Immunoreactive bands were 
detected with an ECL prime Western Blotting Detection Reagent (Amersham) in a 
ChemiDoc™ MP Imager (Biorad). Optical densities of the immunoreactive bands were 
measured using the ImageLab™ (Biorad) and ImageJ analysis softwares.
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Indirect Immunofluorescence
Cells were fixed with 4% paraformaldehyde for 15 min, permeabilized for 15 min with 0.1% 
Triton X-100, and incubated in blocking buffer containing 10% goat serum for 1h. Cover 
slips were incubated with an antibody against monoclonal complex V α subunit and a Texas 
Red-conjugated anti-mouse secondary antibody (Abcam). Cover slips were rinsed, mounted 
in ProLong Gold antifade reagent (Molecular Probes) on glass slides, and cells were viewed 
with a Zeiss LSM 510 Meta confocal microscope and a 63× planapochromat oil inmersion 
objective (NA: 1.42). Sequential scanning of green and red channels was performed to avoid 
bleed-through effect. Cells were imaged randomly with 0,5-1,0 μm slices and 1024×1024 
pixels resolution. For colocalization analysis, the “Merge channels” plugin from the ImageJ 
1.48v software was used.
Statistical Data Analysis
All experiments were performed at least in triplicate and results were presented as mean ± 
standard deviation (SD) values. Statistical p values were obtained by application of the 
Friedman and Mann-Whitney U tests using the SPSS v21.0 program.
Ethics Statement
This study was performed in accordance with the guidelines of the Federation of European 
Laboratory Animal Science Associations. The protocol was approved by the Landesamt für 
Natur, Umwelt und Verbraucherschutz in Nordrhein-Westfalen in Germany.
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Highlights
1. COX7A2L preferentially interacts with respiratory chain complex III
2. COX7A2L is essential to stabilize the III2+IV supercomplex
3. COX7A2L is not necessary for biogenesis or maintenance of the 
respirasome
4. Biogenesis of the III2+IV supercomplex is not necessary for 
respirasome formation
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Figure 1. Mouse COX7A2L behaves as a complex III-binding protein specifically required for SC 
III2+IV assembly
(A) Supramolecular organization of the respiratory chain in heart mitochondria from wild-
type CD1, C57BL/6J and C57BL/6N (Lrpprc wt) mouse strains, as well as from Lrpprc 
deficient mice with a C57BL/6N genetic background. Mitochondria were extracted with a 
digitonin:protein ratio of 4 g/g and analyzed by BN-PAGE followed by CI and CIV-IGA 
assays. (B) Heart mitochondria were extracted with a digitonin:protein ratio of 6 g/g and 
analyzed by BN-PAGE followed by western blot with double fluorescent detection of CIII 
and CIV (anti-CORE2 or anti-COX1, green color) and COX7A2L-containing complexes 
(anti-COX7A2L, red color). White asterisks show the localization of SC III2+IV. (C) Heart 
mitochondria were extracted with a digitonin:protein ratio of 4 g/g and analyzed by 2D-BN/
SDS-PAGE followed by western blot and immunodetection with antibodies against 
COX7A2L and the indicated OXPHOS subunits. (D) Import of radiolabeled RISP and 
COX7A2L precursors and subsequent incorporation into CIII and SCs in intact heart 
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mitochondria from C57BL/6J and CD1 mouse strains. After the indicated incubation times 
(in minutes), mitochondria were solubilized in 6 g/g digitonin per protein and analyzed by 
BN-PAGE. I+III2+IVn, SC containing CI, CIII and CIV. I+III2, SC containing CI and CIII. 
III2+IV, SC containing CIII and CIV. III2, complex III dimer; IV, free complex IV; IVn, 
complex IV oligomers. See also Figure S1.
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Figure 2. Human COX7A2L comigrates with respiratory chain supercomplexes and free 
complexes III and IV
(A) Mitochondria from control 143B cells and mutant cybrids defective in complexes I (CI-
KD), III (CIII-KO) and IV (CIV-KO) were extracted with a digitonin:protein ratio of 4 g/g 
and analyzed by 2D-BN/SDS-PAGE and western blot with antibodies raised against 
COX7A2L, CORE2 and COX1. (B) Mitochondrial lysates from control and mutant cybrids 
were analyzed by SDS- PAGE and western blot with the indicated antibodies. (C) BN-PAGE 
and CI-IGA analysis of control 143B cells and CIV-KO mutant cybrids. After Coomassie 
staining, the SC I+III2+IV1 band was excised from the control lane and the bands 
corresponding to SC I+III2 and CIII were excised from the CIV-KO lane. Bands were 
subsequently analyzed by liquid chromatography coupled to tandem mass spectrometry. (D) 
MS/MS spectra from the doubly-charged COX7A2L tryptic peptide unambiguously detected 
by LC-ESI/MS in two independent experiments per sample. The amino acid sequence of the 
identified COX7A2L unique peptide is highlighted in red. The most intense signals on the 
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MS/MS spectra correspond to the main fragmentation series (b-amino and y-carboxy). 
Doubly-charged fragments are marked with superscript 2+. I+III2+IVn, SC containing CI, 
CIII and CIV. I+III2, SC containing CI and CIII. III2+IV, SC containing CIII and CIV. III2, 
complex III dimer. IV, complex IV. IV2, complex IV dimer. See also Table S1 and Figure S2.
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Figure 3. Overexpressed COX7A2L localizes to mitochondria with minor effects on the 
respiratory chain complexes and supercomplexes
(A) Confocal microscopy of 143B cells transiently transfected with the COX7A2L-GFP 
construct and with the empty-GFP vector as a control. Upper images show the GFP signal. 
Middle images show the mitochondrial network using an antibody against the ATPase a 
subunit. Lower images show the overlay between the two signals. (B) BN-PAGE and 
western-blot analyses of control 143B cells transiently transfected both with the COX7A2L-
GFP or COX7A2L-MYC-DDK constructs, and with their corresponding empty vectors. 
Membranes were incubated with antibodies raised against COX7A2L and the indicated 
OXPHOS subunits. (C) Densitometric analysis of the MRC complexes and SCs in 143B 
cells transfected with both COX7A2L- tagged constructs. The optical densities of 
immunoreactive bands that had not reached saturation levels were measured with the 
ChemiDoc™ MP Image Analyzer software package (Biorad). The antibody signals within 
the same structures were quantified; the mean values were normalized by CII and expressed 
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as percentages of the cells transfected with the empty vectors (horizontal bar). Values 
represent the mean ± SD from four independent experiments. I+III2+IVn, SC containing CI, 
CIII and CIV. III2+IV, SC containing CIII and CIV. III2, complex III dimer. IV, complex IV. 
IV2, complex IV dimer. II, complex II. See also Figure S3.
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Figure 4. COX7A2L physically binds complexes III and IV
(A) COX7A2L co-immunoprecipitation assay. Digitonin-solubilized mitochondrial extracts 
(4 g digitonin / g protein) from HEK293 cells transiently transfected with COX7A2L-MYC-
DDK (+) or the empty MYC-DDK construct (-) were immunoprecipitated using an anti-
DDK antibody. (B) The same digitonin-solubilized mitochondrial extracts were 
immunoprecipitated using antibodies against CORE2, or (C) against COX1. Samples were 
subsequently analyzed by SDS-PAGE and western blot with the indicated antibodies.
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Figure 5. Assembly kinetics of COX7A2L in free complexes and supercomplexes
(A) Mitochondria from doxycycline-treated 143B cells were extracted with a 
digitonin:protein ratio of 4 g/g and analyzed by 2D-BN/SDS-PAGE and western blot with 
the indicated antibodies. (B) Densitometric profiles representing the assembly progress of 
COX7A2L in CIII- and CIV- containing structures. (C) Mean incorporation rates of 
COX7A2L into CIII- and CIV- containing structures. The signals from three independent 
experiments were quantified and normalized by CII. Time point values are expressed as 
percentages of the untreated cells (SS), and indicated as means ± SD. I+III2+IVn, SC 
containing CI, CIII and CIV. III2+IV, SC containing CIII and CIV. III2, complex III dimer. 
IV, complex IV. See also Figure S4.
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Figure 6. COX7A2L binds to complex III assembly intermediates
(A) Digitonin-solubilized mitochondrial extracts (4 g digitonin / g protein) from HeLa cells 
transduced with the MZM1L-HA contruct or with the empty vector (PuroR) were analyzed 
by BN-PAGE and CI-IGA assays or alternatively, by western blot and immunodetection. 
Asterisks indicate unspecific signals that do not appear on 2D-BN/SDS-PAGE gels. (B) 
Subsequent 2D-BN/SDS-PAGE and western blot analyses were performed with antibodies 
against COX7A2L, the indicated OXPHOS subunits and the HA epitope. I+III2+IVn, SC 
containing CI, CIII and CIV. I+III2, SC containing CI and CIII. I*, complex I-containing 
structure. III2+IV, SC containing CIII and CIV. Pre-III2+IV, SC containing pre-CIII and CIV. 
III2, complex III dimer. Pre-III2, pre-CIII lacking the RISP subunit. IV, complex IV; IV2, 
complex IV dimer. II, complex II. Subcomplexes that contain CORE2 and COX1 are 
indicated as subCORE2 and subCOX1, respectively. The association of RISP and MZM1L 
is indicated as RISP+MZM1L.
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Figure 7. COX7A2L down regulation specifically decreases the levels of supercomplex III2+IV 
without affecting respirasome biogenesis
The effect of COX7A2L knockdown on MRC complex assembly was investigated in 
untreated (CO), mock-transfected (C-), and COX7A2L siRNA-transfected (i) 143B cells and 
in the CIV-KO mutants. (A) Mitochondria were extracted with a digitonin:protein ratio of 4 
g/g and analyzed by BN-PAGE followed by CI-IGA assays, or alternatively, by western blot 
and immunodetection with the indicated antibodies. (B) 2D-BN/SDS-PAGE and western 
blot analyses of 143B cells upon COX7A2L silencing. (C) The optical densities of 
immunoreactive bands that had not reached saturation levels were measured. The signals 
within SC III2+IV were quantified, normalized by CII, and shown as means ± SD from five 
independent siRNA experiments. Values are expressed as percentages of the cells transfected 
with scramble RNA (C-, horizontal bar). I+III2+IVn, SC containing CI, CIII and CIV. I+III2, 
SC containing CI and CIII. III2+IV, SC containing CIII and CIV. III2, complex III dimer. IV, 
complex IV. IV2, complex IV dimer. II, complex II. See also Figures S5 and S6.
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